Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-chloro-4-(((1r,2s)-1-(5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl)-2-hydroxypropyl)amino)-3-methylbenzonitrile
2. Rad 140
3. Rad-140
4. Rad140
1. Rad140
2. 1182367-47-0
3. Vosilasarm
4. Rad-140
5. 4o87q44knc
6. 2-chloro-4-[[(1r,2s)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile
7. Chembl1672635
8. 2-chloro-4-(((1r,2s)-1-(5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl)-2-hydroxypropyl)amino)-3-methylbenzonitrile
9. 2-chloro-4-((1r,2s)-1-(5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl)-2-hydroxypropylamino)-3-methylbenzonitrile
10. Benzonitrile, 2-chloro-4-(((1r,2s)-1-(5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl)-2-hydroxypropyl)amino)-3-methyl-
11. Vosilasarm [inn]
12. Unii-4o87q44knc
13. Vosilasarm [who-dd]
14. Testolone [nflis-drug]
15. Schembl1363683
16. Ex-a725
17. Rad140,
18. Dtxsid201032907
19. Bcp16214
20. Bdbm50336997
21. Mfcd20527233
22. S5275
23. Zinc66097792
24. Ccg-268578
25. Cs-4670
26. Db13939
27. Ncgc00485476-01
28. 2-chloro-4-({1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl}amino)-3-methylbenzonitrile
29. Ac-30220
30. Hy-14383
31. J-690050
32. Q25099854
33. 2-chloro-4-[[(1r,2s)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazole-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile
Molecular Weight | 393.8 g/mol |
---|---|
Molecular Formula | C20H16ClN5O2 |
XLogP3 | 3.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 393.0992525 g/mol |
Monoisotopic Mass | 393.0992525 g/mol |
Topological Polar Surface Area | 119 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 623 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
51
PharmaCompass offers a list of Vosilasarm API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vosilasarm manufacturer or Vosilasarm supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vosilasarm manufacturer or Vosilasarm supplier.
PharmaCompass also assists you with knowing the Vosilasarm API Price utilized in the formulation of products. Vosilasarm API Price is not always fixed or binding as the Vosilasarm Price is obtained through a variety of data sources. The Vosilasarm Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A RAD 140 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of RAD 140, including repackagers and relabelers. The FDA regulates RAD 140 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. RAD 140 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of RAD 140 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A RAD 140 supplier is an individual or a company that provides RAD 140 active pharmaceutical ingredient (API) or RAD 140 finished formulations upon request. The RAD 140 suppliers may include RAD 140 API manufacturers, exporters, distributors and traders.
click here to find a list of RAD 140 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
RAD 140 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of RAD 140 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right RAD 140 GMP manufacturer or RAD 140 GMP API supplier for your needs.
A RAD 140 CoA (Certificate of Analysis) is a formal document that attests to RAD 140's compliance with RAD 140 specifications and serves as a tool for batch-level quality control.
RAD 140 CoA mostly includes findings from lab analyses of a specific batch. For each RAD 140 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
RAD 140 may be tested according to a variety of international standards, such as European Pharmacopoeia (RAD 140 EP), RAD 140 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (RAD 140 USP).